IceCure Medical (ICCM) Shares Outstanding (2020 - 2026)

IceCure Medical (ICCM) has reported Shares Outstanding (Entity) for 6 consecutive years, with $2.4 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Shares Outstanding (Entity) rose 29.26% year-over-year to $2.4 million in Q4 2025; TTM through Dec 2025 was $2.4 million, a 29.26% increase from a year earlier, with the FY2025 full-year figure at $2.4 million, up 29.26% from the prior year.
• Shares Outstanding (Entity) was $2.4 million for Q4 2025 at IceCure Medical, up from $1.9 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $2.4 million in Q4 2025 and troughed at $951623.0 in Q4 2021.
• A 5-year average of $1.6 million and a median of $1.5 million in 2023 frame the typical range for Shares Outstanding (Entity).
• Across the five-year window, Shares Outstanding (Entity) soared 41.2% in 2021 and rose 23.54% in 2023, its largest moves.
• Over 5 years, Shares Outstanding (Entity) stood at $951623.0 in 2021, then gained by 29.66% to $1.2 million in 2022, then rose by 23.54% to $1.5 million in 2023, then grew by 23.7% to $1.9 million in 2024, then grew by 29.26% to $2.4 million in 2025.
• The last three Shares Outstanding (Entity) figures came in at $2.4 million (Q4 2025), $1.9 million (Q4 2024), and $1.5 million (Q4 2023), per Business Quant data.